142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

310924
Knowledge, attitude, and testing differentials of inner-city African American, Caucasian and Hispanic men regarding prostate cancer screening experience in the Southside community of Chicago, Illinois

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 9:00 AM - 9:15 AM

Patrick B. Williams, PhD., CHES , College of Health Scidences, Chicago State University, Chicago, IL
Quintin L. Williams Jr., PhD , Department of Health Studies, Chicago State University, Chicago, IL
Ivonne Anguh, MPH, MBA, PhDc , College of Health Sciences, Chicago State University, Chicago, IL
Cindy L. , Morgan-King, BS, MPHc , College of Health Sciences, Chicago State University, Chicago, IL
Yahanna M. Diemer, BS , College of Health Sciences, Chicago State University, Chicago, IL
Amarachi Agada,, BS, MPHc , College of Health Sciences, Chicago State University, Chicago, IL

Background: Prostate cancer is the most commonly diagnosed cancer among men in the United States. Disparities in the rate of diagnosis and mortality of prostate cancer in recent years have revealed the age-adjusted rates of 145.1/100,000, 226.0/100,000, 121.6/100,000, respectively for Caucasian, African American (AA), and Hispanic men.

 Methods:  We conducted a cross-sectional study from 2012-2014 among diverse ethnic male groups aged 35 to 75 years from Chicago Southside. To determine the knowledge of risk factors, symptoms of prostate cancer, screening, testing, and differences among the men on prostate cancer, we utilized a 23-item knowledge/attitude questionnaire to ascertain prostate specific antigen (PSA) test and digital rectal examination (DRE) screening results, intention to screen, as well as, family history of prostate cancer among participants.

 Results: Of the 550 respondents, 15.6% were Caucasian, 20.7% Hispanic and 63.7% AA. Twenty one point five percent were aged 50 years and below, 23.5% had a high school education, 40.8% had a Bachelors degree or higher, 60% had low knowledge scores, while 38.5% had a medium knowledge score. Specifically, 23.2%, 20.5%, 16.5% had received prostate cancer information from relations/friends/neighbors, TV, and Clinic/Doctor's office, respectively. About 54% of the participants had PSA screening. Caucasians were more likely to be interested in digital rectal examination (p<0.001). Ethnicity was not associated with the other outcome variables. However, education was associated with PSA/DRE screening (p=0.05).

Conclusion: Chicago Southside population has limited knowledge and minimal screening experience. Evidence-based prostate cancer mass education intervention is warranted for this population.

Learning Areas:

Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs

Learning Objectives:
Identify which groups of participants were more likely to know the risk factors of prostate cancer and participate in early prostate cancer screening experience. Identify factors more likely to prevent the participants from early screening for prostate cancer using either DRE or PSA testing procedure or both.

Keyword(s): Cancer and Men’s Health, Cancer Prevention and Screening

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a professor of public health and have published extensively in the field. I am devoted to community-based research on health disparities, behavioral health and disease prevention strategies with focus on HIV/AIDS, other sexually transmitted infections, cardiovascular diseases as well as malignant neoplasm among underserved populations, minority groups, the poor, and other high-risk populations. I've extensively presented papers at national and international public health conferences and has published scientific research papers in my field.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.